PI3K/AKT activates mammalian target of rapamycin (mTOR) and further inhibits autophagy in FLS, promoting the continuous abnormal proliferation of synovial cells, and it is also critical for the survival and differentiation of osteoclasts, aggravating RA [20]. Here, MTOR is linked to rheumatoid arthritis.